Cline Darren S 4
4 · PLIANT THERAPEUTICS, INC. · Filed Mar 8, 2023
Insider Transaction Report
Form 4
Cline Darren S
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-03-06+22,000→ 22,000 totalExercise: $31.11Exp: 2033-03-06→ Common Stock (22,000 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of March 6, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.